
Peter Anthopolos
Examiner (ID: 5946, Phone: (571)270-5989 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611 |
| Total Applications | 621 |
| Issued Applications | 329 |
| Pending Applications | 62 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19510422
[patent_doc_number] => 20240342108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => GREEN METHOD OF PRODUCING CIRCLE-SHAPED SILVER NANOPARTICLES USING ETHYL ACETATE EXTRACT OF URTICA DIOICA LEAVES
[patent_app_type] => utility
[patent_app_number] => 18/134980
[patent_app_country] => US
[patent_app_date] => 2023-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134980 | GREEN METHOD OF PRODUCING CIRCLE-SHAPED SILVER NANOPARTICLES USING ETHYL ACETATE EXTRACT OF URTICA DIOICA LEAVES | Apr 13, 2023 | Pending |
Array
(
[id] => 18496123
[patent_doc_number] => 20230218667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
[patent_app_type] => utility
[patent_app_number] => 18/122478
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122478
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122478 | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses | Mar 15, 2023 | Issued |
Array
(
[id] => 19884101
[patent_doc_number] => 12269793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Affinity illudofulvene conjugates
[patent_app_type] => utility
[patent_app_number] => 18/175495
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 56
[patent_no_of_words] => 42426
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175495
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175495 | Affinity illudofulvene conjugates | Feb 26, 2023 | Issued |
Array
(
[id] => 18449382
[patent_doc_number] => 20230190658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/112747
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112747 | MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME | Feb 21, 2023 | Abandoned |
Array
(
[id] => 19440007
[patent_doc_number] => 12090234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Compositions and methods related to megakaryocyte-derived extracellular vesicles
[patent_app_type] => utility
[patent_app_number] => 18/100821
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 33
[patent_no_of_words] => 49079
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100821
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100821 | Compositions and methods related to megakaryocyte-derived extracellular vesicles | Jan 23, 2023 | Issued |
Array
(
[id] => 20057341
[patent_doc_number] => 20250195563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/730182
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18730182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/730182 | METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES | Jan 18, 2023 | Pending |
Array
(
[id] => 18449652
[patent_doc_number] => 20230190928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CONTROLLED RELEASE VACCINE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/154304
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154304
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154304 | CONTROLLED RELEASE VACCINE FORMULATION | Jan 12, 2023 | Abandoned |
Array
(
[id] => 19798826
[patent_doc_number] => 20250064751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => STABLE FORMULATIONS OF LIPID-ENCAPSULATED RNA
[patent_app_type] => utility
[patent_app_number] => 18/726667
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/726667 | STABLE FORMULATIONS OF LIPID-ENCAPSULATED RNA | Jan 8, 2023 | Pending |
Array
(
[id] => 19798921
[patent_doc_number] => 20250064846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => TREATMENT AND PREVENTION OF TRIGEMINAL NEURALGIA
[patent_app_type] => utility
[patent_app_number] => 18/726735
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726735
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/726735 | TREATMENT AND PREVENTION OF TRIGEMINAL NEURALGIA | Jan 5, 2023 | Pending |
Array
(
[id] => 18365954
[patent_doc_number] => 20230147545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SHEET-SHAPED MEMBER
[patent_app_type] => utility
[patent_app_number] => 18/091176
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/091176 | Sheet-shaped member | Dec 28, 2022 | Issued |
Array
(
[id] => 18339947
[patent_doc_number] => 20230131896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => COSMETIC COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/086725
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086725 | Cosmetic compositions and methods of use | Dec 21, 2022 | Issued |
Array
(
[id] => 18449771
[patent_doc_number] => 20230191047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => MEDICAL COUNTER MEASURES INCLUDING DRY POWDER FORMULATIONS AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/082311
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 106565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082311 | Medical counter measures including dry powder formulations and associated methods | Dec 14, 2022 | Issued |
Array
(
[id] => 18365926
[patent_doc_number] => 20230147517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/076012
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076012 | LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF | Dec 5, 2022 | Abandoned |
Array
(
[id] => 18466983
[patent_doc_number] => 20230201263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR
[patent_app_type] => utility
[patent_app_number] => 18/071010
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18071010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/071010 | Pretreatment drug for T cell infusion therapy for immune-checkpoint inhibitor-resistant tumor | Nov 28, 2022 | Issued |
Array
(
[id] => 18197303
[patent_doc_number] => 20230050822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 17/970906
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970906 | COMPOSITIONS AND METHODS FOR TREATING BIOFILMS | Oct 20, 2022 | Abandoned |
Array
(
[id] => 18325342
[patent_doc_number] => 20230123470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => MICROENCAPSULATION OF NICOTINE FOR TOBACCOLESS ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/047375
[patent_app_country] => US
[patent_app_date] => 2022-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047375
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047375 | MICROENCAPSULATION OF NICOTINE FOR TOBACCOLESS ORAL ADMINISTRATION | Oct 17, 2022 | Abandoned |
Array
(
[id] => 18278579
[patent_doc_number] => 20230094051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DIMETHYLTRIPTAMINE-BASED NASAL SPRAY FOR THE PERSONALISED TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/957640
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/957640 | DIMETHYLTRIPTAMINE-BASED NASAL SPRAY FOR THE PERSONALISED TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Sep 29, 2022 | Abandoned |
Array
(
[id] => 18091180
[patent_doc_number] => 20220409521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => COMPOSITION FOR COSMETICS
[patent_app_type] => utility
[patent_app_number] => 17/902742
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902742 | COMPOSITION FOR COSMETICS | Sep 1, 2022 | Abandoned |
Array
(
[id] => 18544151
[patent_doc_number] => 11717482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Inhalable antimicrobial particles and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/823239
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23293
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823239 | Inhalable antimicrobial particles and methods of making the same | Aug 29, 2022 | Issued |
Array
(
[id] => 18328181
[patent_doc_number] => 11633396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one
[patent_app_type] => utility
[patent_app_number] => 17/821833
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 14105
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821833 | Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one | Aug 23, 2022 | Issued |